Northern Trust Corp Novo Cure LTD Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Novo Cure LTD stock. As of the latest transaction made, Northern Trust Corp holds 923,509 shares of NVCR stock, worth $28.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

923,509

Previous 501,449 84.17%

Holding current value

$28.4 Million

Previous $8.59 Million 68.05%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$15.61 - $23.34 $6.59 Million - $9.85 Million	422,060 Added 84.17%	923,509 $14.4 Million
Q2 2024 Aug 14, 2024	BUY	$11.83 - $24.05 $43,309 - $88,047	3,661 Added 0.74%	501,449 $8.59 Million
Q1 2024 May 14, 2024	BUY	$12.42 - $17.29 $38,154 - $53,114	3,072 Added 0.62%	497,788 $7.78 Million
Q4 2023 Feb 13, 2024	BUY	$11.13 - $15.78 $619,618 - $878,488	55,671 Added 12.68%	494,716 $7.39 Million
Q3 2023 Nov 13, 2023	SELL	$16.15 - $42.35 $2.33 Million - $6.1 Million	-143,992 Reduced 24.7%	439,045 $7.09 Million
Q2 2023 Aug 11, 2023	SELL	$40.29 - $82.51 $1.39 Million - $2.84 Million	-34,381 Reduced 5.57%	583,037 $24.2 Million
Q1 2023 May 15, 2023	BUY	$56.44 - $118.81 $808,728 - $1.7 Million	14,329 Added 2.38%	617,418 $37.1 Million
Q4 2022 Feb 13, 2023	BUY	$63.98 - $85.37 $197,122 - $263,024	3,081 Added 0.51%	603,089 $44.2 Million
Q3 2022 Nov 14, 2022	SELL	$67.99 - $89.57 $1.4 Million - $1.85 Million	-20,603 Reduced 3.32%	600,008 $45.6 Million
Q2 2022 Aug 12, 2022	SELL	$56.6 - $89.9 $941,031 - $1.49 Million	-16,626 Reduced 2.61%	620,611 $43.1 Million
Q1 2022 May 13, 2022	BUY	$60.15 - $84.52 $180,810 - $254,067	3,006 Added 0.47%	637,237 $52.8 Million
Q4 2021 Feb 08, 2022	SELL	$75.08 - $121.99 $49,552 - $80,513	-660 Reduced 0.1%	634,231 $47.6 Million
Q3 2021 Nov 15, 2021	BUY	$116.17 - $194.55 $5.82 Million - $9.74 Million	50,087 Added 8.56%	634,891 $73.8 Million
Q2 2021 Aug 13, 2021	BUY	$130.4 - $225.58 $2.55 Million - $4.4 Million	19,524 Added 3.45%	584,804 $130 Million
Q1 2021 May 12, 2021	BUY	$124.11 - $190.17 $115,670 - $177,238	932 Added 0.17%	565,280 $74.7 Million
Q4 2020 Feb 11, 2021	BUY	$112.16 - $174.14 $11.5 Million - $17.9 Million	102,760 Added 22.26%	564,348 $97.7 Million
Q3 2020 Nov 16, 2020	BUY	$58.05 - $111.31 $9.46 Million - $18.1 Million	163,010 Added 54.6%	461,588 $51.4 Million
Q2 2020 Aug 14, 2020	SELL	$57.2 - $74.41 $37.2 Million - $48.4 Million	-650,544 Reduced 68.54%	298,578 $17.7 Million
Q1 2020 May 14, 2020	SELL	$57.05 - $95.75 $2.19 Million - $3.68 Million	-38,456 Reduced 3.89%	949,122 $63.9 Million
Q4 2019 Feb 14, 2020	SELL	$68.3 - $93.8 $2.39 Million - $3.29 Million	-35,055 Reduced 3.43%	987,578 $83.2 Million
Q3 2019 Nov 13, 2019	BUY	$61.86 - $97.8 $8.55 Million - $13.5 Million	138,177 Added 15.62%	1,022,633 $76.5 Million
Q2 2019 Aug 13, 2019	BUY	$42.22 - $63.23 $3.93 Million - $5.89 Million	93,128 Added 11.77%	884,456 $55.9 Million
Q1 2019 May 13, 2019	BUY	$31.96 - $56.12 $354,692 - $622,819	11,098 Added 1.42%	791,328 $38.1 Million
Q4 2018 Feb 12, 2019	SELL	$28.72 - $52.63 $696,201 - $1.28 Million	-24,241 Reduced 3.01%	780,230 $26.1 Million
Q3 2018 Nov 14, 2018	BUY	$32.0 - $52.4 $1.52 Million - $2.49 Million	47,512 Added 6.28%	804,471 $42.2 Million
Q2 2018 Sep 18, 2018	SELL	$19.85 - $32.0 $110,445 - $178,048	-5,564 Reduced 0.73%	756,959 $23.7 Million
Q2 2018 Aug 14, 2018	BUY	$19.85 - $32.0 $4.08 Million - $6.58 Million	205,562 Added 36.91%	762,523 $23.9 Million
Q1 2018 May 09, 2018	SELL	$19.3 - $23.65 $57,417 - $70,358	-2,975 Reduced 0.53%	556,961 $12.1 Million
Q4 2017 Feb 14, 2018	SELL	$16.3 - $21.9 $308,640 - $414,676	-18,935 Reduced 3.27%	559,936 $11.3 Million
Q3 2017 Nov 13, 2017	BUY	$18.05 - $21.75 $10.4 Million - $12.6 Million	578,871	578,871 $11.5 Million

Others Institutions Holding NVCR

# of Institutions

263

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Novo Cure LTD Transaction History